查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869877

冠狀動脈繞道手術手術市場規模、佔有率和趨勢分析報告：按技術、手術方式、最終用途、地區和細分市場預測（2025-2033 年）

Coronary Artery Bypass Graft Market Size, Share & Trends Analysis Report By Method (On-pump, Off-pump), By Surgical Procedure (Single CABG Surgery, Double CABG Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

冠狀動脈繞道手術手術市場摘要

2024年全球冠狀動脈繞道手術手術市場規模估計為192.4億美元，預計2033年將達到276.6億美元。

預計從2025年到2033年，該市場將以3.86%的複合年成長率成長。心血管疾病盛行率的上升是推動市場成長的主要因素之一。

根據牛津學術出版社2025年1月發表的報導，心血管疾病的全球負擔依然沉重，年齡已調整的盛行率約為每10萬人7179例。如此高的盛行率凸顯了對有效治療方法的日益成長的需求，特別是對冠狀動脈疾病的治療方法，冠狀動脈疾病是心血管相關疾病和死亡的主要原因。

冠狀動脈疾病 (CAD) 盛行率的不斷上升正在推動市場成長。根據美國疾病管制與預防美國(CDC) 於 2024 年 10 月發布的報告，CAD 影響著美國約 5% 的成年人（20 歲及以上），即近 1/20 的人患有 CAD。如此高的盛行率凸顯了 CAD 的持續挑戰，CAD 仍然是心臟相關疾病和死亡的主要原因之一。對於許多患者而言，晚期 CAD 病例需要手術干預，因為微創治療效果有限。因此，冠狀動脈繞道手術手術 (CABG) 仍然是一種至關重要的治療方法，這不僅鞏固了其在整體心血管護理中的重要性，也凸顯了其作為市場格局關鍵促進因素的作用。

移植技術的進步正為冠狀動脈繞道手術（CABG）帶來更有效、更持久的解決方案。例如，2025年7月，創新植入開發商Xeltis推出了Xabg，一種人工合成冠狀動脈繞道手術移植血管（CABG）。這種創新移植血管旨在促進血管內皮細胞自然形成，進而維持血管的通暢。歐盟臨床試驗的初步數據顯示，Xabg在多支血管粥狀硬化性冠狀動脈疾病患者中具有良好的安全性和通暢率。 Xabg是移植技術的突破性進展，旨在透過促進內皮細胞生長並整合到患者自身血管系統中，克服傳統移植血管的限制。

此外，機器人技術在冠狀動脈繞道手術（CABG）的應用正在改變手術方式，提高手術精準度並降低創傷。根據OAE Publishing Inc.於2025年8月發表的報導，機器人輔助CABG正逐漸成為傳統開胸手術的一種微創替代方案，可減少手術創傷並加速康復。具體技術包括機器人輔助微創直接冠狀動脈繞道手術（RA-MIDCAB），該手術使用機器人採集內乳動脈，並透過小切口進行吻合。還有完全內視鏡冠狀動脈繞道手術（TECAB），該手術完全避免了開胸。這些進步正在重塑手術計劃和實施，提高冠狀動脈重組手術的精確度並降低創傷。

在美國，冠狀動脈繞道手術（CABG）的報銷格局正在迅速變化，反映出醫療產業向價值醫療模式的轉變。引入綜合支付模式以簡化報銷流程並提升醫療品質是一大趨勢。根據美國心臟學會基金會（ACCF）2024年4月發布的公告，美國醫療保險和醫療補助服務中心（CMS）已提案一項強制性的醫院按病程付費模式－「轉型病程責任制模式」（TEAM），該模式將於2026年1月開始實施。此模式整合了冠狀動脈繞道術（CABG）和其他高成本手術的支付，確保報銷更加可預測，並鼓勵醫院最佳化診療路徑，從而改善患者預後。

除了打包支付之外，醫師收費標準（PFS）的更新也影響報銷趨勢。根據Atricure的報導，將於2025年1月1日生效的Medicare PFS將修訂冠狀動脈旁路移植術（CABG）的報銷費率，使單支動脈移植CABG（CPT代碼33533）的費用約為1789美元。這些調整將提高醫院和外科醫生進行複雜心血管手術的合理報酬，並確保支付與目前的臨床實踐和營運成本相符。

此外，微創冠狀動脈繞道手術（CABG）醫療覆蓋範圍的擴大，反映了人們對先進外科手術方法的接受度不斷提高。自2025年1月起，羅德島藍十字藍盾保險公司更新了其醫療保險政策，將微創直接冠狀動脈繞道手術（MIDCAB）納入健保範圍。該政策認可微創手術的許多好處，包括縮短恢復時間和改善患者預後。然而，其他微創手術方法，例如經皮冠狀動脈繞道手術移植術（PACAB）和全內視鏡冠狀動脈繞道手術（TECAB），由於缺乏改善預後的證據，仍不在醫保覆蓋範圍內。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章冠狀動脈繞道手術手術市場變數、趨勢與範圍

  • 市場體系展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 冠狀動脈繞道手術手術：市場分析工具
    • 產業分析—波特五力分析
    • PESTLE分析
  • 未來機會分析
    • 組織工程血管移植物（TEVG）
    • 高風險多支血管冠狀動脈疾病（CAD）患者對冠狀動脈繞道手術（CABG）的需求不斷增加
    • 將人工智慧和影像技術整合到術前規劃中
  • 技術格局
    • 技術和程序創新
    • 移植材料的進展
    • 3D列印在外科手術規劃的應用
  • 冠狀動脈繞道手術市場的臨床和手術趨勢
  • 案例研究
  • 冠狀動脈繞道手術的替代方案

第4章冠狀動脈繞道手術手術市場區隔分析（依技術分類，2021-2033年）

  • 定義和範圍
  • 技術市場佔有率分析，2024 年和 2033 年
  • 細分儀表板
  • 全球冠狀動脈繞道手術手術市場（依技術分類），2021-2033年
  • 非泵送
  • 泵浦上
  • 微創直接冠狀動脈繞道手術（MIDCAB）

第5章冠狀動脈繞道手術手術市場區隔分析（依手術方式分類），2021年至2033年

  • 定義和範圍
  • 外科手術市場佔有率分析，2024 年和 2033 年
  • 細分儀表板
  • 全球冠狀動脈繞道手術手術市場（依手術方式分類，2021-2033 年）
  • 單次冠狀動脈繞道手術
  • 雙側冠狀動脈繞道手術
  • 三重冠狀動脈旁路移植術
  • 四重冠狀動脈繞道手術

第6章冠狀動脈繞道手術手術市場區隔分析（依最終用途分類），2021年至2033年

  • 定義和範圍
  • 2024 年及 2033 年終端用戶市佔率分析
  • 細分儀表板
  • 全球冠狀動脈繞道手術手術市場（依最終用途分類），2021-2033年
  • 醫院
  • 心臟病中心
  • 其他

第7章冠狀動脈繞道手術手術市場細分分析，依地區、技術、手術方式、最終用途分類，2021-2033年

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場概覽
  • 區域市場概況
  • 2024 年及 2033 年各地區冠狀動脈繞道手術手術市佔率：
  • 北美洲
    • 2021-2033年北美冠狀動脈繞道手術手術市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲冠狀動脈繞道手術手術市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司簡介
    • Medtronic
    • Terumo Corporation
    • Getinge AB
    • WL Gore &Associates, Inc.
    • B. Braun SE
    • Abbott.
    • LivaNova plc
    • Transonic
    • Edwards Lifesciences
    • Vascular Graft Solutions
Product Code: GVR-1-68038-426-0

Coronary Artery Bypass Graft Market Summary

The global coronary artery bypass graft market size was estimated at USD 19.24 billion in 2024 and is projected to reach USD 27.66 billion by 2033, growing at a CAGR of 3.86% from 2025 to 2033. Increasing the prevalence of cardiovascular disease is one of the key aspects driving market growth.

According to an Oxford Academic article published in January 2025, the global burden of cardiovascular disease remains substantial, with an age-standardized prevalence of approximately 7,179 cases per 100,000 individuals. This high prevalence underlines the growing need for effective treatment options, particularly for coronary artery disease, which is a leading contributor to cardiovascular-related morbidity and mortality.

The increasing incidence of CAD drives market growth. According to the CDC article published in October 2024, in the U.S., coronary artery disease (CAD) affects a significant portion of the population, with nearly 1 in 20 adults aged 20 years and older, approximately 5% living with the condition. This sizable patient pool highlights the ongoing clinical challenge posed by CAD, which remains a leading cause of heart-related morbidity and mortality. For many individuals, advanced cases of CAD require surgical intervention when less invasive treatments prove insufficient. As a result, coronary artery bypass grafting (CABG) continues to serve as a vital therapeutic approach, reinforcing its importance within the broader cardiovascular treatment landscape and underscoring its role as a key driver of market demand.

Advancements in graft technology are paving the way for more effective and durable solutions in CABG procedures. For instance, in July 2025, Xeltis, a transformative implant developer, introduced Xabg, a synthetic coronary artery bypass conduit (CABG). This innovative graft is designed to enable the natural creation of living and long-lasting vessels. Preliminary clinical data from an EU clinical trial have demonstrated positive safety and patency outcomes among patients with multi-vessel atherosclerotic coronary artery disease. Xabg represents a significant advancement in graft technology, aiming to address the limitations of traditional grafts by promoting endothelial cell growth and integration with the patient's vascular system.

Moreover, integrating robotics into CABG procedures transforms surgical approaches, offering enhanced precision and reduced invasiveness. According to OAE Publishing Inc., an article published in August 2025, Robotic-assisted CABG has emerged as a minimally invasive alternative to traditional open-heart surgery, offering reduced surgical trauma and faster recovery. Techniques include robotic-assisted minimally invasive direct coronary artery bypass (RA-MIDCAB), where the internal thoracic artery is harvested robotically and anastomosed via mini-thoracotomy, and totally endoscopic CABG (TECAB), which avoids thoracotomy altogether. These advancements reshape operative planning and execution, enhancing precision and reducing invasiveness in coronary revascularization procedures.

The landscape of CABG reimbursement in the U.S. is evolving rapidly, reflecting the healthcare industry's push toward value-based care. A significant trend is the introduction of bundled payment models that streamline reimbursement and incentivize quality. According to the American College of Cardiology Foundation in April 2024, the Centers for Medicare & Medicaid Services (CMS) proposed the Transforming Episode Accountability Model (TEAM), a mandatory hospital episode-based payment model set to start in January 2026. This model bundles payments for CABG surgeries and other high-cost procedures, ensuring more predictable reimbursement and encouraging hospitals to optimize care pathways for improved patient outcomes.

Parallel to bundled payments, physician fee schedule updates have shaped reimbursement trends. According to an Atricure article, effective January 1, 2025, the Medicare Physician Fee Schedule (PFS) revised reimbursement rates for CABG procedures, including the single arterial graft CABG (CPT code 33533) at approximately USD 1,789. These adjustments ensure payments align with current clinical practice and operational costs, reinforcing fair compensation for hospitals and surgeons performing complex cardiac procedures.

Moreover, expanding coverage for minimally invasive CABG techniques reflects increasing acceptance of advanced surgical approaches. As of January 2025, Blue Cross Blue Shield of Rhode Island updated its medical policy to cover Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) surgery. The policy recognizes the benefits of less invasive procedures, such as reduced recovery times and enhanced patient outcomes. However, other minimally invasive approaches, such as Port Access CABG (PACAB) and Total Endoscopic CABG (TECAB), remain excluded due to limited evidence of improved outcomes.

Global Coronary Artery Bypass Graft Market Report Segmentation

This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global coronary artery bypass graft market report based on method, surgical procedure, end-use, and region:

  • Method Outlook (Revenue USD Million, 2021 - 2033)
  • Off-pump
  • On-pump
  • Minimally Invasive Direct CABG (MIDCAB)
  • Surgical Procedure Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
  • Single CABG Surgery
  • Double CABG Surgery
  • Triple CABG Surgery
  • Quadruple CABG Surgery
  • End-use Outlook (Revenue USD Million, 2021 - 2033)
  • Hospitals
  • Cardiology Centers
  • Others
  • Regional Outlook (Revenue USD Million, 2021 - 2033) (Procedure Volume, In Thousand, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Spain
    • Italy
    • France
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Method outlook
    • 2.2.2. Surgical Procedure outlook
    • 2.2.3. End Use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary Artery Bypass Graft Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising cardiovascular (CVD) and coronary artery disease (CAD) prevalence
      • 3.2.1.2. Technological advances in grafts & robotics
      • 3.2.1.3. Increasing favorable reimbursement policies for CABG
      • 3.2.1.4. Increasing favorable reimbursement policies for CABG
      • 3.2.1.5. AI-Guided Intra-Operative Imaging Adoption
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Operational and procedural hurdles restrict advanced CABG techniques
      • 3.2.2.2. Surgical complexity and associated risks in CABG
  • 3.3. Coronary Artery Bypass Graft: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Future Opportunity Analysis
    • 3.4.1. Tissue-Engineered Vascular Grafts (TEVGs)
    • 3.4.2. Growing CABG Demand In High-Risk, Multi-Vessel CAD Patients
    • 3.4.3. AI and Imaging Integration In Pre-Surgical Planning
  • 3.5. Technology Landscape
    • 3.5.1. Technological And Procedural Innovations
    • 3.5.2. Advancements In Graft Materials
    • 3.5.3. 3D Printing In Surgical Planning
  • 3.6. Clinical & Procedural Trends in the CABG Market
  • 3.7. Case Studies
  • 3.8. Alternative Methods to CABG

Chapter 4. Coronary Artery Bypass Graft Market Segment Analysis, By Method, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Method Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Coronary Artery Bypass Graft Market, by Method, 2021 - 2033
  • 4.5. Off-pump
    • 4.5.1. Off-pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. On-pump
    • 4.6.1. On-pump market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Minimally Invasive Direct CABG (MIDCAB)
    • 4.7.1. Minimally Invasive Direct CABG (MIDCAB) market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Coronary Artery Bypass Graft Market Segment Analysis, By Surgical Procedure, 2021 - 2033 (USD Million) (Thousands)

  • 5.1. Definition and Scope
  • 5.2. Surgical Procedure Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Coronary Artery Bypass Graft Market, by Surgical Procedure, 2021 - 2033
  • 5.5. Single CABG Surgery
    • 5.5.1. Single CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Single CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
  • 5.6. Double CABG Surgery
    • 5.6.1. Double CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Double CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
  • 5.7. Triple CABG Surgery
    • 5.7.1. Triple CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Triple CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)
  • 5.8. Quadruple CABG Surgery
    • 5.8.1. Quadruple CABG surgery market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.8.2. Quadruple CABG surgery market estimates and forecasts, 2021 - 2033 (In Thousand)

Chapter 6. Coronary Artery Bypass Graft Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Coronary Artery Bypass Graft Market, by end use, 2021 - 2033
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Cardiology Centers
    • 6.6.1. Cardiology Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Coronary Artery Bypass Graft Market Segment Analysis, By Region, By Method, By Surgical Procedure, By End Use, 2021 - 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Coronary Artery Bypass Graft Market Share by Region, 2024 & 2033:
  • 7.5. North America
    • 7.5.1. North America Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.5.2.5. U.S. Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.5.3.5. Canada Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.5.4. Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.5.4.5. Mexico Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.6. Europe
    • 7.6.1. Europe Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.2.5. UK Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.3.5. Germany Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.4.5. France Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.5.5. Italy Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.6.5. Spain Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.7.5. Norway Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.8.5. Sweden Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory Framework & Reimbursement Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.6.9.5. Denmark Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.1.5. Japan Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.2.5. China Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.3.5. India Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.4.5. Australia Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.5.5. South Korea Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory Framework & Reimbursement Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.7.6.5. Thailand Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.8.1.5. Brazil Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.8.2.5. Argentina Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.9.1.5. South Africa Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.9.2.5. Saudi Arabia Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.9.3.5. UAE Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory Framework & Reimbursement Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait Coronary Artery Bypass Graft Market, 2021 - 2033 (USD Million)
      • 7.9.4.5. Kuwait Coronary Artery Bypass Graft Market, 2021 - 2033 (In Thousand)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Medtronic
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Terumo Corporation
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Getinge AB
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. W. L. Gore & Associates, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. B. Braun SE
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Abbott.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. LivaNova plc
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Transonic
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Edwards Lifesciences
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Vascular Graft Solutions
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 4. Global Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 5. Global Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (In Thousand)
  • Table 6. Global Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7. Global Coronary Artery Bypass Graft Market, By Region, 2021 - 2033 (USD Million)
  • Table 8. North America Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 9. North America Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 10. North America Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 11. North America Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 12. North America Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13. U.S. Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 14. U.S. Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 15. U.S. Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 16. U.S. Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17. Canada Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 18. Canada Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 19. Canada Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 20. Canada Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21. Mexico Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 22. Mexico Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 23. Mexico Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 24. Mexico Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25. Europe Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 26. Europe Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 27. Europe Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 28. Europe Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 29. Europe Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30. UK Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 31. UK Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 32. UK Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 33. UK Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34. Germany Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 35. Germany Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 36. Germany Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 37. Germany Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38. France Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 39. France Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 40. France Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 41. France Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42. Italy Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 43. Italy Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 44. Italy Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 45. Italy Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46. Spain Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 47. Spain Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 48. Spain Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 49. Spain Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50. Denmark Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 51. Denmark Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 52. Denmark Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 53. Denmark Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54. Sweden Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 55. Sweden Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 56. Sweden Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 57. Sweden Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58. Norway Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 59. Norway Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 60. Norway Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 61. Norway Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62. Asia Pacific Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 63. Asia Pacific Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 64. Asia Pacific Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 65. Asia Pacific Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 66. Asia Pacific Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67. Japan Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 68. Japan Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 69. Japan Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 70. Japan Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71. China Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 72. China Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 73. China Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 74. China Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75. India Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 76. India Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 77. India Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 78. India Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79. Australia Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 80. Australia Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 81. Australia Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 82. Australia Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83. Thailand Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 84. Thailand Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 85. Thailand Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 86. Thailand Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87. South Korea Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 88. South Korea Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 89. South Korea Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 90. South Korea Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91. Latin America Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 92. Latin America Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 93. Latin America Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 94. Latin America Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 95. Latin America Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96. Brazil Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 97. Brazil Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 98. Brazil Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 99. Brazil Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100. Argentina Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 101. Argentina Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 102. Argentina Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 103. Argentina Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104. Middle East & Africa Coronary Artery Bypass Graft Market, By Country, 2021 - 2033 (USD Million)
  • Table 105. Middle East & Africa Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 106. Middle East & Africa Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 107. Middle East and Africa Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 108. Middle East & Africa Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109. South Africa Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 110. South Africa Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 111. South Africa Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 112. South Africa Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113. Saudi Arabia Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 114. Saudi Arabia Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 115. Saudi Arabia Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 116. Saudi Arabia Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117. UAE Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 118. UAE Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 119. UAE Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 120. UAE Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121. Kuwait Coronary Artery Bypass Graft Market, By Method, 2021 - 2033 (USD Million)
  • Table 122. Kuwait Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 (USD Million)
  • Table 123. Kuwait Coronary Artery Bypass Graft Market, By Surgical Procedure, 2021 - 2033 Procedure Volume (In Thousand)
  • Table 124. Kuwait Coronary Artery Bypass Graft Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Coronary artery bypass graft market: outlook
  • Fig. 8 Coronary artery bypass graft competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Coronary artery bypass graft market driver impact
  • Fig. 11 Coronary artery bypass graft market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Coronary artery bypass graft market: Method movement analysis
  • Fig. 15 Coronary artery bypass graft market: Method outlook and key takeaways
  • Fig. 16 Off-pump market estimates and forecast, 2021 - 2033
  • Fig. 17 On-pump market estimates and forecast, 2021 - 2033
  • Fig. 18 Minimally Invasive Direct CABG (MIDCAB) market estimates and forecast, 2021 - 2033
  • Fig. 19 Coronary artery bypass graft market: Surgical procedure movement analysis
  • Fig. 20 Coronary artery bypass graft market: Surgical procedure outlook and key takeaways
  • Fig. 21 Single CABG surgery market estimates and forecasts, 2021 - 2033
  • Fig. 22 Double CABG surgery market estimates and forecasts, 2021 - 2033
  • Fig. 23 Triple CABG surgery market estimates and forecasts, 2021 - 2033
  • Fig. 24 Quadruple CABG surgery market estimates and forecasts, 2021 - 2033
  • Fig. 25 Coronary artery bypass graft market: End Use movement analysis
  • Fig. 26 Coronary artery bypass graft market: End Use outlook and key takeaways
  • Fig. 27 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 28 Cardiology centers market estimates and forecasts,2021 - 2033
  • Fig. 29 Others centers market estimates and forecasts, 2021 - 2033
  • Fig. 30 Global coronary artery bypass graft market: Regional movement analysis
  • Fig. 31 Global coronary artery bypass graft market: Regional outlook and key takeaways
  • Fig. 32 North America coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 33 Key country dynamics
  • Fig. 34 US coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 37 Key country dynamics
  • Fig. 38 Mexico coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 39 Europe coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 44 Key country dynamics
  • Fig. 45 Spain coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 46 Key country dynamics
  • Fig. 47 France coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 50 Key country dynamics
  • Fig. 51 Norway coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 54 Key country dynamics
  • Fig. 55 Sweden coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 56 Asia Pacific coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 59 Key country dynamics
  • Fig. 60 China coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 61 Key country dynamics
  • Fig. 62 India coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 69 Latin America coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 70 Key country dynamics
  • Fig. 71 Brazil coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 72 Key country dynamics
  • Fig. 73 Argentina coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 74 MEA coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 75 Key country dynamics
  • Fig. 76 South Africa coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 77 Key country dynamics
  • Fig. 78 Saudi Arabia coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 79 Key country dynamics
  • Fig. 80 UAE coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 81 Key country dynamics
  • Fig. 82 Kuwait coronary artery bypass graft market estimates and forecasts, 2021 - 2033 (USD Million) (In Thousand)
  • Fig. 83 Key company categorization
  • Fig. 84 Heat map analysis, 2024